Eagle Pharmaceuticals Inc
EGRX
Market Cap$25.79M
Close$
$12.59
640.5% upside
Current Fair Value
640.5% upsideUndervalued by 640.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $25.79 Million |
|---|---|
| Enterprise Value | $140.66 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $2.76 |
| Beta | 0.64 |
| Outstanding Shares | 13,090,852 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 0.72 |
|---|---|
| PEG | -0.47 |
| Price to Sales | 0.09 |
| Price to Book Ratio | 0.09 |
| Enterprise Value to Revenue | 0.55 |
| Enterprise Value to EBIT | 4.65 |
| Enterprise Value to Net Income | 11 |
| Total Debt to Enterprise | 0.93 |
| Debt to Equity | 0.52 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Eagle Pharmaceuticals Inc
CEO: Scott Tarriff